Nasal drug has been extensively used and due to its efficacy its popularity is rising. Research and development has helped in making it more effective with less and less harm. This report talks about different market aspect of Nasal Drug Delivery Technology. Market drivers that can affect its growth and Delvens' analyst view on this market.

1. Nasal Drug Delivery
Technology Market
Trend
Report and Industry Analysis on
Nasal Drug Delivery Technology Market

2. Business
Strategies
and
Consultant

3. Business
Introduction
Market
Introduction
Primary
Respondent
Report
Segmentation
Contact Us
Continent
Breakdown
Our Services
Research
Methodology
Table Of Contents

4. Our
Company
Delvens is a market research and consulting
company headquartered in Delhi, India. The
company holds expertise in providing
syndicated research reports, customized
research reports, and consulting services.
Delvens qualitative and quantitative data is
highly utilized by each level from niche
markets to major markets, serving more
than 800 prominent companies by assuring
to provide the information on country,
regional, and global business environment.
We have a database for more than 45
industries in more than 50+ major countries
globally.

5. Nasal Drug Delivery
Technology
Market
An Introduction to the Nasal Drug
Delivery Technology

6. Introduction
Drugs enter the systemic circulation via a variety of routes, including oral, parenteral
(intravenous, intramuscular), and intramuscular administration. In most cases, drugs
administered via these routes undergo acidic or enzymatic degradation and may experience
an excessive first-pass effect (hepatic metabolism) following administration. Because of
these characteristics, appropriate pharmacological dosages may not always reach the
systemic circulation, resulting in inefficient therapy. As a result, it is necessary to investigate
alternative routes or specialized delivery technologies that can result in enhanced and
effective medication delivery solutions. The nasal route of drug administration is one such
alternative route that allows access to highly vascularized mucosa, which can be used as an
intriguing site for local, systemic, and targeted drug delivery (CNS).

7. The worldwide nasal medication delivery technology market is expected to be worth USD
64.20 billion by 2021, growing at a 6.5 percent CAGR during the forecast period.
North America dominated the market with a revenue share of 36.21 percent in 2017. This
growth was connected to an increase in sickness prevalence as well as consumer awareness
of nasal products. According to the CDC, about 20.4 million people in the United States aged
18 and above had asthma in 2017, accounting for around 8.3 percent of the total population.
Furthermore, around 6.1 million children under the age of 18 have asthma. The established
economies of North America will fuel significant development in the next years.
Asia Pacific is expected to have the fastest CAGR of 7.5 percent in the next years. This growth
is mostly due to the availability of effective treatment processes, considerable unmet clinical
demands, growing disposable income levels, and improved consumer
Market Prospect

8. awareness of these products. Furthermore, the presence of key companies in this space,
such as Aptar Group, Inc., Sun Pharmaceutical Industries Ltd., and Cipla Inc., is expected to
assist the industry as a whole.
Europe is the second largest market for nasal medicine delivery technology, owing to
increased R&D activities and rising cigarette consumption. According to the World Health
Organization, Europe has the highest incidence of adult tobacco use (28%) and some of the
highest rates of adolescent tobacco use.

9. Market Drivers
According to a nasal drug delivery technology report analysis, some of the primary factors
driving the growth of the nasal drug delivery technology market include rising patient
preference for nasal medication delivery due to ease of administration and improved
efficacy, an increase in the incidence of chronic diseases, and increased acceptance of
self-administration practices. One of the most common drug delivery strategies among
both consumers and healthcare practitioners is intranasal medication administration. This
is mostly owing to the non-invasive nature of the nasal route and the fact that medicine
absorbability is higher via the nasal route.
Companies have used new technology to create products that are compact, portable, and
simple to use. Because it enables a speedier onset of action for the treatment of associated
disorders, the nasal route has been regarded acceptable for pharmaceutical
administration.

10. Over the forecast period, the concerns related with nasal spray overuse are projected to
impede the growth of the nasal medicine delivery technology market. Regulatory barriers
may limit the growth of the nasal medicine delivery technology market in the near future.
The COVID-19 pandemic benefitted the nasal drug delivery industry by increasing the use of
inhalers at home rather than in hospitals or outpatient clinics since many patients chose to
do their chronic respiratory ailment medication therapy at home. Nasal inhalers are
increasingly being used to treat asthma, migraines, and other mental illnesses. Furthermore,
a number of pharmaceutical companies have begun to develop vaccines that use nasal drug
delivery technology, with some of them currently in clinical studies.

11. Recent Development
● In 2020, the European Joint Programme on Rare Diseases issued a request for firms
to address four obstacles. One of the tasks, sponsored by the Italian pharmaceutical
company Chiesi, was to design a delivery device for intranasal administration of
biological medicines to newborns.
● Eli Lilly recognised 3D printing as a means to deliver medications to particular
sections of the gastrointestinal system, prompting the company to collaborate with
Triastek on the targeted release of molecules in the gut.

12. Conclusions
Factors such as rising patient preference for nasal medication and increased acceptance of
self-administration has helped in gaining the popularity for nasal drugs. Also pandemic has
helped in rising the market of nasal drug. However, concerns related to nasal spray
overuse has led the regulatory authorities to limit its use but with new research and
development, this technology may overcome this barrier.

13. Designation
Breakdown
Breakdown of our data collection from
People of different Designation

14. Sales
Manager
Their
contribution is
about 25%
CEO
They are the major
contributor with
35%
Product
Manager
30% of our primary
respondents
Distributors
10% of our data
come from them
Primary
Respondent

15. Continent
Breakdown
Breakdown of our data collection
from different continents

17. Report Segmentation
Containers
Systems
Therapeutic
Application
Dosage
Form
End-User
Region

18. On the basis of Dosage Form
● Nasal Spray
● Nasal Drops & Liquids
● Nasal Gel
● Nasal Powder
On the basis of Container
● Non-pressurized Container
● Pressurized Container
On the basis of system
● Multi-dose
● Bi-dose
● Unit Dose

19. On the basis of Therapeutic Application
● Allergic and Non-Allergic Rhinitis
● Nasal Congestion
● Vaccination
On the basis of End-User
● Hospital
● Home Healthcare

20. On the basis of Region
● North America
● South America
● Asia Pacific
● Europe
● Middle East & Africa

21. How to Purchase the Report
Delvens offers many customisation to cater your need. Our popular customisation is that our report
is segmented as per user where you got option to choose from:
● Single User
● Multiple User
● Corporate User
If you want report for Globally, Regional or Country specific, then voila, we also provide an easy
step to choose from continent-wise as well as country-wise report. If you have any special
requirement or you want more customization, you can contact our customer representative who are
24X7 available for you.
You can talk to our representative by clicking
Contact Us

22. Get latest and trending updates throughout the year on the reports you buy.
No. Of Pages 376
Report
Global
Regional
Country Specific
User
Single
Multi
Corporate

23. Research Methodology
Data Extraction
Market
Integration
Data Analysis Data Validation

24. Data Extraction
The stage involves the procurement of market data or related information via different sources &
methodologies.
Data Analysis
This step involves the analysis & mapping of all the information procured from the previous step. It also
encompasses the analysis of data discrepancies observed across various data sources.
Market Integration
The final step entails the placement of data points at appropriate market spaces in an attempt to deduce
viable conclusions. Analyst perspective & subject matter expert based heuristic form of market sizing also
plays an integral role in this step.
Data Validation
Validation is the most important step in the process. Validation & re-validation via an intricately designed
process helps us finalize data-points to be used for final calculations.

25. Our Services
1
Syndicated Research
3
Custom Research
Services
3
5
Implementation
Support
1
7
Subscription Model
1
2 Best Practice Guide
4 Consulting Services
3
6
Audio-Video
Infographic Workshop
8 Bundle Reports Model

26. Thank You